Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial

Journal:
Nature Medicine
Published:
Affiliations:
23
Authors:
22
Institutions Authors Share
Roche, Switzerland
8.000000
0.36
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
1.250000
0.06
Copenhagen University Hospital (CUH), Denmark
1.000000
0.05
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Netherlands
1.000000
0.05
Yonsei Cancer Hospital, South Korea
1.000000
0.05
Hospital Universitario 12 de Octubre, Spain
1.000000
0.05
Oxford University Hospitals NHS Trust (OUH), United Kingdom (UK)
1.000000
0.05
Asan Medical Center (AMC), South Korea
1.000000
0.05
Roche Products Limited, United Kingdom (UK)
1.000000
0.05
F. Hoffmann-La Roche Ltd., Switzerland
1.000000
0.05
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain
1.000000
0.05
START Madrid-CIOCC, Spain
0.500000
0.02
Clara Campal Comprehensive Cancer Center HM CIOCC, Spain
0.500000
0.02
Vall d'Hebron Research Institute (VHIR), HUVH ICS, Spain
0.500000
0.02
The Christie NHS Foundation Trust, United Kingdom (UK)
0.500000
0.02
The University of Manchester (UoM), United Kingdom (UK)
0.500000
0.02
Hospital del Mar Medical Research Institute (IMIM), Spain
0.500000
0.02
Clínica Universidad de Navarra (CUN), UNAV, Spain
0.250000
0.01
University of Navarra (UNAV), Spain
0.250000
0.01
University of Oxford, United Kingdom (UK)
0.250000
0.01